Your browser doesn't support javascript.
loading
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
Polonsky, William H; Giorgino, Francesco; Rosenstock, Julio; Whitmire, Katherine; Lew, Elisheva; Coudert, Mathieu; Alvarez, Agustina; Nicholls, Charlie; McCrimmon, Rory J.
Afiliação
  • Polonsky WH; Behavioral Diabetes Institute, San Diego, California.
  • Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas.
  • Whitmire K; Southwest Medical Associates, Las Vegas, Nevada.
  • Lew E; Sanofi, Chilly-Mazarin, France.
  • Coudert M; Biostatistics and Programming Department, Sanofi, Chilly-Mazarin, France.
  • Alvarez A; Sanofi, Buenos Aires, Argentina.
  • Nicholls C; Sanofi, Reading, UK.
  • McCrimmon RJ; Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
Diabetes Obes Metab ; 24(12): 2364-2372, 2022 12.
Article em En | MEDLINE | ID: mdl-36053820
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article